| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/21/2000 | EP1009806A2 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues |
| 06/21/2000 | EP1009769A1 N-terminal modifications of rantes and methods of use |
| 06/21/2000 | EP1009760A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 06/21/2000 | EP1009753A1 Hypoxia-regulated genes |
| 06/21/2000 | EP1009743A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
| 06/21/2000 | EP1009741A1 Novel carboxylic acid derivatives, their production and their use as mixed et a?/et b? endothelin-receptor antagonists |
| 06/21/2000 | EP1009738A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 06/21/2000 | EP1009737A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 06/21/2000 | EP1009730A1 New pentaerythritol derivatives, their production and use and intermediates for their synthesis |
| 06/21/2000 | EP1009447A1 Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same |
| 06/21/2000 | EP1009427A1 USE OF FACTOR XIIIa INHIBITORS TO TREAT ATHEROSCLEROSIS |
| 06/21/2000 | EP1009426A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase |
| 06/21/2000 | EP1009417A1 Dietary supplements containing natural ingredients |
| 06/21/2000 | EP1009400A1 Combination therapy comprising atorvastatin and an antihypertensive agent |
| 06/21/2000 | EP1009236A1 Evaluation of, delivery of, and use of agents to treat heart disorders |
| 06/21/2000 | DE19858779A1 New 3-acylamino-propionic acid and 3-sulfonylamino-propionic acid derivatives useful as endothelin receptor antagonists in treatment of e.g. cardiovascular and renal disorders, migraine and cancer |
| 06/21/2000 | DE19858331A1 Tricyclische Stickstoffheterocyclen als PDE IV Inhibitoren Tricyclic nitrogen heterocycles as PDE IV inhibitors |
| 06/21/2000 | CN1257539A Short peptides which selectively modulate intracellular signalling |
| 06/21/2000 | CN1257538A Short peptides which selectively modulate the activity of serine/threonine kinases |
| 06/21/2000 | CN1257499A 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors |
| 06/21/2000 | CN1257478A Nitro-benzamide useful as anti-arrhythmic agent |
| 06/21/2000 | CN1257474A New nitromethyl ketones, process for preparing them and compositions containing them |
| 06/21/2000 | CN1257429A Use of low-molecular-weight heparins for preventing and treating cerebral edemas |
| 06/21/2000 | CN1257427A Method of treating isolated systolic hypertension |
| 06/21/2000 | CN1257426A Use of fumaric acid derivatives |
| 06/21/2000 | CN1256946A Chinese herbal medicine for treating haemorrhoid |
| 06/21/2000 | CN1256932A Oral liquid for depressing blood pressure |
| 06/21/2000 | CN1256926A Pill for treating hemiplegia |
| 06/21/2000 | CN1256918A Application of lotucine in pharmacy |
| 06/21/2000 | CN1053591C Nitroglycerine adhesive plaster and process for preparing same |
| 06/21/2000 | CN1053571C Application of proliferation in preparation of medicine for inhibiting smooth muscle cell and restinosis |
| 06/20/2000 | US6077861 Modulators of the large-conductance calcium-activated potassium (bk) channels, therefore, useful in the treatment of ischemic stroke |
| 06/20/2000 | US6077841 For treating sexual disorders, male impotency, heart failure, pulmonary hypertension, and angina |
| 06/20/2000 | CA2210241C Pharmaceutical composition containing cyclosporin for treating a human with nervous insult |
| 06/20/2000 | CA2198536C Method of reducing tissue damage associated with ischemia |
| 06/20/2000 | CA2013381C Selective adenosine receptor compounds |
| 06/20/2000 | CA1341029C Peptidase inhibitors |
| 06/15/2000 | WO2000034780A2 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3? |
| 06/15/2000 | WO2000034515A1 Use of factor x polymorphism in the diagnosis and treatment of factor x and/or factor xa mediated diseases |
| 06/15/2000 | WO2000034474A2 Growth factor homolog zvegf3 |
| 06/15/2000 | WO2000034468A2 Muc-1 antagonists and methods of treating immune disorders |
| 06/15/2000 | WO2000034451A1 Treatment of pompe's disease |
| 06/15/2000 | WO2000034338A2 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 06/15/2000 | WO2000034334A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF |
| 06/15/2000 | WO2000034332A1 Glp-1 analogues |
| 06/15/2000 | WO2000034331A2 Analogues of glp-1 |
| 06/15/2000 | WO2000034330A1 Cark protein and nucleic acid molecules and uses therefor |
| 06/15/2000 | WO2000034314A1 Pharmaceutical compositions comprising quinapril magnesium |
| 06/15/2000 | WO2000034313A1 Procollagen c-proteinase inhibitors |
| 06/15/2000 | WO2000034295A2 Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 06/15/2000 | WO2000034284A1 2,5-diazabicyclo[2.2.1]heptane derivatives, their preparation and therapeutic uses |
| 06/15/2000 | WO2000034283A1 Novel triazolo(4,5-d)pyrimidine compounds |
| 06/15/2000 | WO2000034263A1 Benzofuran derivatives, their preparation and use |
| 06/15/2000 | WO2000034248A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 06/15/2000 | WO2000034244A1 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators |
| 06/15/2000 | WO2000034236A1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE |
| 06/15/2000 | WO2000034228A1 Ion channel modulating agents |
| 06/15/2000 | WO2000033979A1 Apparatus for separating particles of cohesive material according to size and process |
| 06/15/2000 | WO2000033876A1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
| 06/15/2000 | WO2000033865A1 Methods of inhibiting ectopic calcification |
| 06/15/2000 | WO2000033848A1 Methods and compositions for prevention and treatment of restenosis with non-steroidal anti-inflammatory drugs |
| 06/15/2000 | WO2000033847A1 Micronized eplerenone compositions |
| 06/15/2000 | WO2000033844A1 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
| 06/15/2000 | WO2000033842A1 Myt1 kinase inhibitors |
| 06/15/2000 | WO2000033841A1 Myt1 kinase inhibitors |
| 06/15/2000 | WO2000033838A1 Vitronectin receptor antagonist |
| 06/15/2000 | WO2000033837A2 Myt1 kinase inhibitors |
| 06/15/2000 | WO2000033834A1 Use of isatin derivatives as ion channel activating agents |
| 06/15/2000 | WO2000033828A1 Agent for lowering endothelin levels |
| 06/15/2000 | WO2000033825A2 Compositions and methods for amelioration of human female sexual dysfunction |
| 06/15/2000 | WO2000033817A1 Phospholipid compositions |
| 06/15/2000 | WO2000033790A2 Methods and compositions for prevention and treatment of arterial lesions with non-steroidal anti-inflammatory drugs |
| 06/15/2000 | WO2000033667A2 Bioflavonoids, anthocyanins and phenol compounds from cherries as antioxidants |
| 06/15/2000 | WO2000015649A9 METHODS OF INHIBITING SMOOTH MUSCLE CELL PROLIFERATION AND PREVENTING RESTENOSIS WITH A VECTOR EXPRESSING RB2/p130 |
| 06/15/2000 | WO2000015231A8 Adenosine a3 receptor modulators |
| 06/15/2000 | WO2000010536A8 Extended release buccal bioadhesive tablet |
| 06/15/2000 | WO2000009711A3 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
| 06/15/2000 | WO2000006701A9 Improvement of cardiac function by mesenchymal stem cell transplantation |
| 06/15/2000 | WO2000005369A3 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis |
| 06/15/2000 | WO1999045016A3 Novel prodrugs for phosphorus-containing compounds |
| 06/15/2000 | DE19857609A1 Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen Use of erythropoietin for the treatment of cerebral ischaemias of the human |
| 06/15/2000 | DE19857009A1 Zubereitung mit verbesserter therapeutischer Breite, enthaltend Nukleotidsyntheseinhibitoren Preparation with improved therapeutic index containing nucleotide synthesis |
| 06/15/2000 | CA2778047A1 Analogues of glp-1 |
| 06/15/2000 | CA2354644A1 Muc-1 antagonists and methods of treating immune disorders |
| 06/15/2000 | CA2354266A1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
| 06/15/2000 | CA2354189A1 Methods of inhibiting ectopic calcification |
| 06/15/2000 | CA2354142A1 Reversible aqueous ph sensitive lipidizing reagents, compositions and methods of use |
| 06/15/2000 | CA2354040A1 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
| 06/15/2000 | CA2353773A1 Cark protein and nucleic acid molecules and uses therefor |
| 06/15/2000 | CA2353618A1 Benzofuran derivatives, their preparation and use |
| 06/15/2000 | CA2353522A1 Treatment of pompe's disease |
| 06/15/2000 | CA2353415A1 Vitronectin receptor antagonist |
| 06/15/2000 | CA2352740A1 Procollagen c-proteinase inhibitors |
| 06/15/2000 | CA2352250A1 Apparatus for separating particles of cohesive material according to size and process |
| 06/15/2000 | CA2352178A1 Phospholipid compositions |
| 06/15/2000 | CA2351452A1 Methods and compositions useful for targeting activated vitronectin receptor .alpha.v.beta.3 |
| 06/15/2000 | CA2351060A1 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 06/15/2000 | CA2351059A1 Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 06/15/2000 | CA2349616A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 06/15/2000 | CA2326842A1 Micronized eplerenone compositions |